Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABMTOTCMKTS:ADMTOTCMKTS:AKSYOTCMKTS:TOMDF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00$0.00$0.00▼$0.00N/A1.56N/AN/AADMTADM Tronics Unlimited$0.06$0.06$0.03▼$0.11$3.79M-0.076,049 shsN/AAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/ATOMDFTodos Med$0.00$0.00▼$0.00N/A-0.11814,294 shsN/AThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies0.00%0.00%0.00%+100.00%-33.33%ADMTADM Tronics Unlimited0.00%-4.92%-6.20%-19.66%-25.33%AKSYAksys0.00%0.00%0.00%0.00%0.00%TOMDFTodos Med0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AADMTADM Tronics UnlimitedN/AN/AN/AN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABMTAdvanced Biomedical Technologies 0.00N/AN/AN/AADMTADM Tronics Unlimited 0.00N/AN/AN/AAKSYAksys 0.00N/AN/AN/ATOMDFTodos Med 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABMTAdvanced Biomedical Technologies$270KN/AN/AN/AN/AN/AADMTADM Tronics Unlimited$2.96M1.28N/AN/AN/A∞AKSYAksysN/AN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABMTAdvanced Biomedical Technologies-$510KN/A0.00∞N/AN/AN/AN/AN/AADMTADM Tronics Unlimited-$880KN/A0.00∞N/A-13.47%-49.27%-18.74%7/14/2025 (Estimated)AKSYAksysN/AN/A0.00N/AN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AADMTADM Tronics UnlimitedN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABMTAdvanced Biomedical TechnologiesN/AN/AN/AADMTADM Tronics UnlimitedN/A1.210.78AKSYAksysN/AN/AN/ATOMDFTodos MedN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABMTAdvanced Biomedical TechnologiesN/AADMTADM Tronics UnlimitedN/AAKSYAksysN/ATOMDFTodos MedN/AInsider OwnershipCompanyInsider OwnershipABMTAdvanced Biomedical Technologies34.11%ADMTADM Tronics Unlimited73.00%AKSYAksys3.80%TOMDFTodos MedN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABMTAdvanced Biomedical Technologies20N/AN/ANot OptionableADMTADM Tronics Unlimited2367.59 million18.25 millionNot OptionableAKSYAksys87N/AN/ANot OptionableTOMDFTodos Med7N/AN/ANot OptionableTOMDF, ADMT, ABMT, and AKSY HeadlinesRecent News About These CompaniesTodos os Golos do Dia na UEFA Champions LeagueOctober 25, 2024 | pt.uefa.comPVamos Todos MorrerSeptember 6, 2024 | rtp.ptRTodos Medical Ltd TOMDFApril 5, 2024 | morningstar.comMTodos Medical Ltd.: Todos Medical Announces Insolvency Proceedings in IsraelDecember 23, 2023 | finanznachrichten.deTodos Medical Announces Insolvency Proceedings in IsraelDecember 22, 2023 | finance.yahoo.comTOMDF Historical DataOctober 2, 2023 | investing.comTodos Medical Provides Corporate Update: Retooling to Focus on Long COVID EpidemicSeptember 26, 2023 | finance.yahoo.comTodos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ IngredientsAugust 30, 2023 | finance.yahoo.comTodos Medical Ltd. (TOMDF)May 24, 2023 | finance.yahoo.comTodos Medical's Letter of Intent with Provista Diagnostics set to license sepsis diagnostic testingMarch 31, 2023 | finance.yahoo.comTodos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic testMarch 28, 2023 | proactiveinvestors.comTodos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen DiagnosticsMarch 28, 2023 | finance.yahoo.comTodos Medical Begins Trading on the OTC Pink MarketplaceMarch 27, 2023 | finance.yahoo.comTodos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patientsMarch 17, 2023 | proactiveinvestors.comTodos Medical Supports Long COVID Awareness DayMarch 15, 2023 | finance.yahoo.comTodos Medical Enters Into Moratorium on ConversionsMarch 13, 2023 | vietreader.comVTodos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note HoldersMarch 13, 2023 | finance.yahoo.comTodos Medical releases corporate update around validation plan for PCR-based Avian Influenza testingFebruary 24, 2023 | proactiveinvestors.comTodos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rolloutFebruary 23, 2023 | proactiveinvestors.comTodos Medical says Provista Diagnostics lab kicks off validation plan for PCR-based bird flu test for humansFebruary 14, 2023 | proactiveinvestors.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTOMDF, ADMT, ABMT, and AKSY Company DescriptionsAdvanced Biomedical Technologies OTCMKTS:ABMT$0.0004 0.00 (0.00%) As of 06/27/2025Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.ADM Tronics Unlimited OTCMKTS:ADMT$0.06 0.00 (0.00%) As of 06/27/2025ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.Aksys OTCMKTS:AKSYAksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.Todos Med OTCMKTS:TOMDFTodos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
